320 related articles for article (PubMed ID: 33883388)
1. NLRP3 Inflammasome as a Common Denominator of Atherosclerosis and Abdominal Aortic Aneurysm.
Takahashi M
Circ J; 2021 Nov; 85(12):2129-2136. PubMed ID: 33883388
[TBL] [Abstract][Full Text] [Related]
2. NLRP3 inflammasome as a key driver of vascular disease.
Takahashi M
Cardiovasc Res; 2022 Jan; 118(2):372-385. PubMed ID: 33483732
[TBL] [Abstract][Full Text] [Related]
3. Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.
Usui F; Shirasuna K; Kimura H; Tatsumi K; Kawashima A; Karasawa T; Yoshimura K; Aoki H; Tsutsui H; Noda T; Sagara J; Taniguchi S; Takahashi M
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):127-36. PubMed ID: 25378412
[TBL] [Abstract][Full Text] [Related]
4. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.
Grebe A; Hoss F; Latz E
Circ Res; 2018 Jun; 122(12):1722-1740. PubMed ID: 29880500
[TBL] [Abstract][Full Text] [Related]
5. Role of NLRP3 Inflammasome in Cardiac Inflammation and Remodeling after Myocardial Infarction.
Takahashi M
Biol Pharm Bull; 2019; 42(4):518-523. PubMed ID: 30930410
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
8. Importance of NLRP3 Inflammasome in Abdominal Aortic Aneurysms.
Shi J; Guo J; Li Z; Xu B; Miyata M
J Atheroscler Thromb; 2021 May; 28(5):454-466. PubMed ID: 33678767
[TBL] [Abstract][Full Text] [Related]
9. Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition.
Satish M; Agrawal DK
Transl Res; 2020 Jan; 215():75-85. PubMed ID: 31469975
[TBL] [Abstract][Full Text] [Related]
10. Purinergic receptor P2X7 contributes to abdominal aortic aneurysm development via modulating macrophage pyroptosis and inflammation.
Sun L; Li X; Luo Z; Li M; Liu H; Zhu Z; Wang J; Lu P; Wang L; Yang C; Wang T; He H; Li M; Shu C; Li J
Transl Res; 2023 Aug; 258():72-85. PubMed ID: 36967061
[TBL] [Abstract][Full Text] [Related]
11. Activating α7nAChR ameliorates abdominal aortic aneurysm through inhibiting pyroptosis mediated by NLRP3 inflammasome.
Fu H; Shen QR; Zhao Y; Ni M; Zhou CC; Chen JK; Chi C; Li DJ; Liang G; Shen FM
Acta Pharmacol Sin; 2022 Oct; 43(10):2585-2595. PubMed ID: 35217818
[TBL] [Abstract][Full Text] [Related]
12. Glucose regulates hypoxia-induced NLRP3 inflammasome activation in macrophages.
Watanabe S; Usui-Kawanishi F; Karasawa T; Kimura H; Kamata R; Komada T; Inoue Y; Mise N; Kasahara T; Takahashi M
J Cell Physiol; 2020 Oct; 235(10):7554-7566. PubMed ID: 32115713
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis.
Hettwer J; Hinterdobler J; Miritsch B; Deutsch MA; Li X; Mauersberger C; Moggio A; Braster Q; Gram H; Robertson AAB; Cooper MA; Groß O; Krane M; Weber C; Koenig W; Soehnlein O; Adamstein NH; Ridker P; Schunkert H; Libby P; Kessler T; Sager HB
Cardiovasc Res; 2022 Oct; 118(13):2778-2791. PubMed ID: 34718444
[TBL] [Abstract][Full Text] [Related]
14. Potential Mechanisms and Effects of Chinese Medicines in Treatment of Diabetic Atherosclerosis by Modulating NLRP3 Inflammasome: A Narrative Review.
Yuan JY; Fu Y; Feng ZH; Sang F; Shao MY; Li LL
Chin J Integr Med; 2022 Aug; 28(8):753-761. PubMed ID: 35507299
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin alleviates NLRP3-inflammasome-mediated pyroptosis of aortic endothelial cells by inhibiting FoxO4 in arteriosclerosis.
Zhang L; Yuan M; Zhang L; Wu B; Sun X
Biochem Biophys Res Commun; 2019 Jun; 514(1):266-272. PubMed ID: 31030940
[TBL] [Abstract][Full Text] [Related]
16. The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1β maturation and gasdermin E-mediated pyroptosis.
Li JY; Wang YY; Shao T; Fan DD; Lin AF; Xiang LX; Shao JZ
J Biol Chem; 2020 Jan; 295(4):1120-1141. PubMed ID: 31852739
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction.
Silvis MJM; Demkes EJ; Fiolet ATL; Dekker M; Bosch L; van Hout GPJ; Timmers L; de Kleijn DPV
J Cardiovasc Transl Res; 2021 Feb; 14(1):23-34. PubMed ID: 32648087
[TBL] [Abstract][Full Text] [Related]
18. Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis.
Qiao L; Ma J; Zhang Z; Sui W; Zhai C; Xu D; Wang Z; Lu H; Zhang M; Zhang C; Chen W; Zhang Y
Circ Res; 2021 Dec; 129(12):1141-1157. PubMed ID: 34704457
[TBL] [Abstract][Full Text] [Related]
19. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
Takahashi M
J Cardiovasc Pharmacol; 2019 Sep; 74(3):188-193. PubMed ID: 31356542
[TBL] [Abstract][Full Text] [Related]
20. Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets.
Tanase DM; Valasciuc E; Gosav EM; Ouatu A; Buliga-Finis ON; Floria M; Maranduca MA; Serban IL
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
